Your browser doesn't support javascript.
loading
A Pilot Study of Cisplatin, Irinotecan, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer / Journal of the Korean Cancer Association, 대한암학회지
Cancer Research and Treatment ; : 121-125, 2006.
Artigo em Inglês | WPRIM | ID: wpr-51255
ABSTRACT

PURPOSE:

Irinotecan, in combination with leucovorin/ 5-fluorouracil (FU) or with cisplatin, is known to be active for treating advanced gastric cancer (AGC). This pilot study evaluated a novel three-drug combination of irinotecan, leucovorin/FU and cisplatin as a first-line treatment of AGC. The primary endpoint was to assess the feasibility in anticipation of conducting a larger phase II study. MATERIALS AND

METHODS:

Chemotherapy-naive AGC patients received irinotecan 150 mg/m2 on day 1, and leucovorin 200 mg/m2 and a 22-h infusion of FU 1000 mg/m2 on days 1 and 2. Cisplatin 30 mg/m2 was administered on day 2. Treatment was repeated every 2 weeks until disease progression or unacceptable toxicity.

RESULTS:

Of the 17 eligible patients, two patients had an ECOG performance status of 2 and their median age was 48 years (range 31 to 69). A total of 117 chemotherapy cycles were delivered (median 6, range 1 to 12). The causes of treatment discontinuation were disease progression in 9 patients (53%), refusal (35%) and toxicity (12%). Although grade 3 or 4 neutropenia (41% of patients) was the major toxicity that required dose adjustments, only one episode of febrile neutropenia occurred. Grade 3 or 4 nausea and vomiting, diarrhea and fatigue were observed in 35%, 35% and 29% of patients, respectively. None of the patients died of toxicity during treatment. Of the 16 patients who were evaluable for response, 7 (44%) experienced a partial response.

CONCLUSION:

This novel multi-drug combination was tolerated well in patients with AGC. Based on the encouraging efficacy and tolerability, a randomized phase II study is ongoing in this disease setting.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Neoplasias Gástricas / Vômito / Projetos Piloto / Leucovorina / Cisplatino / Progressão da Doença / Diarreia / Dissulfiram / Tratamento Farmacológico / Quimioterapia Combinada Tipo de estudo: Ensaio Clínico Controlado Limite: Humanos Idioma: Inglês Revista: Cancer Research and Treatment Ano de publicação: 2006 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Neoplasias Gástricas / Vômito / Projetos Piloto / Leucovorina / Cisplatino / Progressão da Doença / Diarreia / Dissulfiram / Tratamento Farmacológico / Quimioterapia Combinada Tipo de estudo: Ensaio Clínico Controlado Limite: Humanos Idioma: Inglês Revista: Cancer Research and Treatment Ano de publicação: 2006 Tipo de documento: Artigo